Sector: MedicalMeridian Bioscience Inc. (NASDAQ: VIVO)
Ranking History
Scan Date: | 11/10/2009 |
Sector: | Medical |
Funamental : | 70 |
Technical : | 167 |
Performance : | 215 |
Overall: | 160 |
Number of Stocks: | 306 |
Scan Date: | 11/3/2009 |
Sector: | Medical |
Funamental : | 67 |
Technical : | 261 |
Performance : | 152 |
Overall: | 176 |
Number of Stocks: | 306 |
Scan Date: | 10/27/2009 |
Sector: | Medical |
Funamental : | 58 |
Technical : | 219 |
Performance : | 146 |
Overall: | 141 |
Number of Stocks: | 306 |
Headlines
- The Bioscience Conference That Thinks Globally
Sep 17, 2009 03:00 PM | PG, VIVO
- Meridian Bioscience Granted Special 510(k) Clearance to Add 2009 H1N1 Influenza A Virus Analytical Sensitivity Claim to the TRU FLU(R) Test Package Insert
Sep 17, 2009 10:44 AM | VIVO
- StockPreacher.com Issues Cautious Trading Outlook for China Medical Technologies Inc.
Sep 16, 2009 06:52 AM | BIO, CMED, IMA, QDEL, VIVO
- Obama Day
Jan 20, 2009 09:56 AM | AIB, BAC, BCS, BRKR, EGLE, EMR
- Lufkin and Quality Systems: Trading Transparency
Aug 09, 2008 12:58 PM | LUFK, QSII, RES, RMD, VIVO
- Meridian Bioscience Rated Hold, Resmed Rated Buy
Aug 06, 2008 07:30 PM | RMD, VIVO
- Ahead Of The Fed
Aug 04, 2008 10:48 AM | AAUK, AKAM, ALY, BIIB, CHD, CHIC
- Meridian Bioscience :Trading Transparency
Jul 17, 2008 04:48 PM | VIVO
- With the new month, it is time for another monthly performance update of my stock screen machine. If you had purchased every stock within my stock screen machine at the closing price on March 31 and held through the closing...
May 01, 2008 12:37 PM | AAPL, ABX, AGU, BBD, BBL, BHP
- NASDAQ Technical Picture - Bullish Week
Apr 25, 2008 12:56 AM | AAPL, ABC, ABK, ACI, AEC, AFFX
- Meridian Bioscience Reports Record Fiscal 2009 Operating Results, Increases Regular Cash Dividend Rate, and Reaffirms Guidance
Nov 12, 2009 07:52 AM | VIVO
- Meridian Bioscience Europe Announces Agreement to Distribute Test For GI Disease
Sep 30, 2009 03:52 PM | VIVO
- Meridian Bioscience Provides Sales and Earnings Guidance for Fiscal 2010 and Reaffirms Fiscal 2009 Guidance
Sep 15, 2009 04:52 PM | VIVO
- Meridian Bioscience to Present at the Robert W. Baird 2009 Health Care Conference
Sep 03, 2009 10:51 AM | VIVO
- Meridian Bioscience Appoints James M. Anderson to Board of Directors
Jul 16, 2009 10:48 AM | VIVO
- Meridian Bioscience Reports Record Sales and Operating Results, Declares Regular Cash Dividend, Reaffirms Fiscal 2009 Guidance, and Comments on Timing of Fiscal 2010 Guidance
Jul 16, 2009 07:53 AM | VIVO
- FORTUNE Small Business Again Lists Meridian Bioscience as One of America’s Fastest-Growing Small Companies
Jul 07, 2009 03:01 PM | VIVO
- Meridian Bioscience to Present at the William Blair and Company’s 29th Annual Growth Stock Conference
Jun 10, 2009 08:01 AM | VIVO
- Meridian Bioscience Wins GHX 2009 Best in Class Award
Jun 04, 2009 10:32 AM | VIVO
- Meridian Bioscience Receives FDA Clearance for New Rapid Campylobacter Test
Jun 03, 2009 02:47 PM | VIVO
- Form 4 MERIDIAN BIOSCIENCE INC For: Nov 17 Filed by: KREIDER GARY P (10K)
Nov 17, 2009 04:44 PM
- Form 4 MERIDIAN BIOSCIENCE INC For: Nov 12 Filed by: ROLIH SUSAN (10K)
Nov 16, 2009 05:53 PM
- Form 4 MERIDIAN BIOSCIENCE INC For: Nov 12 Filed by: MOTTO WILLIAM J (10K)
Nov 16, 2009 05:53 PM
- Form 4 MERIDIAN BIOSCIENCE INC For: Nov 12 Filed by: LUEKE MELISSA (10K)
Nov 16, 2009 05:50 PM
- Form 4 MERIDIAN BIOSCIENCE INC For: Nov 12 Filed by: BALDINI LAWRENCE (10K)
Nov 16, 2009 05:44 PM
- Form 4 INTERNO ANTONIO For: Aug 25 (10K)
Aug 25, 2009 04:35 PM
- Form 4/A Anderson James M. For: Jul 16 (10K)
Aug 25, 2009 11:34 AM
- Form 4 Motto Todd W For: Aug 19 (10K)
Aug 20, 2009 03:19 PM
- Form 4 Anderson James M. For: Aug 06 (10K)
Aug 06, 2009 05:29 PM
- Form 4 Anderson James M. For: Jul 16 (10K)
Jul 20, 2009 09:31 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
VIVO
|
Compare to S&P
|
| YTD |
-13.15 %
|
-28.26 %
|
| 4 Weeks |
-9.53 %
|
-10.01 %
|
| 12 Weeks |
-5.87 %
|
-11.67 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 4.76 %
|
|
EPS Growth in Last Year: 15.79 %
|
|
Sales Growth in Last Quarter: 11.04 %
|
|
Sales Growth in Last Quarter: 16.41 %
|
|
